SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-013786
Filing Date
2020-02-10
Accepted
2020-02-10 17:22:25
Documents
13
Period of Report
2020-02-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207230d1-8k.htm   iXBRL 8-K 32021
2 EXHIBIT 10.1 tm207230d1_ex10-1.htm EX-10.1 24509
  Complete submission text file 0001104659-20-013786.txt   237933

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA akrx-20200204.xsd EX-101.SCH 3177
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE akrx-20200204_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akrx-20200204_pre.xml EX-101.PRE 22704
8 EXTRACTED XBRL INSTANCE DOCUMENT tm207230d1-8k_htm.xml XML 3587
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 20593031
SIC: 2834 Pharmaceutical Preparations